Changes in Digital Speech Measures in Asymptomatic Carriers of Pathogenic Variants Associated With Frontotemporal Degeneration-Reference-Cited by-同舟云学术

Changes in Digital Speech Measures in Asymptomatic Carriers of Pathogenic Variants Associated With Frontotemporal Degeneration

Published:2024-01-23 Issue:2 Volume:102 Page:
ISSN:0028-3878
Container-title:Neurology
language:en
Short-container-title:Neurology

Author:

Nevler Naomi¹^ORCID,Cho Sunghye¹^ORCID,Cousins Katheryn A.Q.¹^ORCID,Ash Sharon¹^ORCID,Olm Christopher A.¹^ORCID,Shellikeri Sanjana¹^ORCID,Agmon Galit¹^ORCID,Gonzalez-Recober Carmen¹^ORCID,Xie Sharon X.¹^ORCID,Barker Megan S.¹^ORCID,Manoochehri Masood¹^ORCID,Mcmillan Corey T.¹^ORCID,Irwin David J.¹^ORCID,Massimo Lauren¹^ORCID,Dratch Laynie¹^ORCID,Cheran Gayathri¹,Huey Edward D.¹,Cosentino Stephanie A.¹^ORCID,Van Deerlin Vivianna M.¹^ORCID,Liberman Mark Y.¹^ORCID,Grossman Murray¹

Affiliation:

1. From the Frontotemporal Degeneration Center, Department of Neurology, (N.N., K.A.Q.C., S.A., C.A.O., S.S., G.A., C.G.-R., C.T.M., D.J.I., L.M., L.D., M.G.), Linguistic Data Consortium, Department of Linguistics (S.C., M.Y.L.), Penn Image Computing and Science Laboratory, Department of Radiology (C.A.O.), Department of Biostatistics, Epidemiology and Informatics (S.X.X.), and Department of Pathology and Laboratory Medicine (V.M.V.D.), Perelman School of Medicine, University of Pennsylvania,...

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Neurology (clinical)

Link

https://www.neurology.org/doi/pdfdirect/10.1212/WNL.0000000000207926

Reference49 articles.

1. Memantine in patients with frontotemporal lobar degeneration: a multicentre, randomised, double-blind, placebo-controlled trial

2. Peripheral GRN mRNA and Serum Progranulin Levels as a Potential Indicator for Both the Presence of Splice Site Mutations and Individuals at Risk for Frontotemporal Dementia

3. Poly‐ GP in cerebrospinal fluid links C9orf72 ‐associated dipeptide repeat expression to the asymptomatic phase of ALS / FTD

4. Plasma Neurofilament Light for Prediction of Disease Progression in Familial Frontotemporal Lobar Degeneration

5. Longitudinal cognitive biomarkers predicting symptom onset in presymptomatic frontotemporal dementia